摘要
目的:探讨人卵巢癌组织表达差异基因,揭示卵巢癌发生、发展的分子机制。方法:2例人卵巢癌组织标本及2例正常人卵巢组织,取自第四军医大学西京医院妇产科手术切除标本。其中2例人卵巢癌组织标本经病理确诊低分化浆液性乳头状囊腺癌,临床诊断为卵巢癌Ⅲ期,临床诊断根据FIGO标准,选用2例正常卵巢组织为对照。提取卵巢组织中mRNA,提取并纯化卵巢癌组织中总RNA,应用cDNA基因芯片技术对共计588个基因进行表达差异基因检测。结果:cDNA基因芯片技术对卵巢癌组织和正常卵巢组织中588个基因同时进行比较,两组中共筛选出表达差异基因44条:其中11条表达上调基因(包括癌基因c-erbB2,neu,c-fos,c-mycproto-oncogenes,HER2 receptor等)、33条表达下调基因(包括RAR,MMP18,MMP19,p21,DNA-PK等)。结论:揭示人卵巢癌组织中表达差异基因,为早期诊断卵巢癌及判断预后提供理想标志物。
Objective: To explore the differently expressed genes, reveal the molecular mechanism of occurrence and development of ovarian carcinoma. Methods : Two specimens of human ovarian carcinoma tissues and two specimens of normal ovarian tissues were select- ed from Department of Gynecology and Obstetrics. The two specimens of human ovarian carcinoma tissues were diagnosed as poorly differenti- ated serous cystadenocarcinoma by pathological examination and ovarian carcinoma of stage Ⅲ by clinical diagnosis according to International Federation of Gynecology and Obstetrics (FIGO) , the two specimens of normal ovarian tissues were selected as control group, mRNA in ovar- ian tissues was extracted, total RNA in ovarian carcinoma was extracted and purified. 588 genes were detected by cDNA gene chip technology for differently expressed genes. Results: The 588 genes in ovarian carcinoma tissues and normal ovarian tissues were compared by cDNA gene chip technology, 44 differently expressed genes were screened out in the two groups : including 11 up - regulation genes ( c - erbB2, neu, c - fos, c - myc proto - oncogenes, HER2 receptor) and 33 down - regulation genes ( RAR, MMP18, MMP19, p21, DNA - PK). Con- clusion: The differently expressed genes in human ovarian carcinoma are ideal markers in early diagnosis and judging prognosis.
出处
《中国妇幼保健》
CAS
北大核心
2010年第15期2129-2132,共4页
Maternal and Child Health Care of China